Search

everythinglearnresearchcommunity

for

Search:↓

Low-level light therapy significantly increased hair density and thickness in people with hair loss, but they didn't notice a difference.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The Laxometer helps make hair transplants with many grafts safer.

Trichorhinophalangeal syndrome causes hair, facial, and bone issues, with no specific treatment beyond gentle care.

Fractional infrared technology is effective and safe for treating cervical laxity.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Increasing Rps14 helps grow more inner ear cells and repair hearing cells in baby mice.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

LustrivaTM improves hair thickness and reduces facial wrinkles safely.

A gene mutation causes curly hair and hair loss in rats.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Low level laser therapy effectively treats alopecia areata on the scalp.